Company news

Futura Medical Plc (LSE:FUM) news

Futura Medical Plc news releases on 6ix. Latest, Jan 18, 2017: Director's dealings

View Futura Medical Plc →

Press releases — page 5

Director's dealings

January 18, 2017

Director / PDMR Dealing and Grant of Options

January 13, 2017

Director / PDMR Dealing and Total Voting Rights

January 12, 2017

Director's Dealings

January 11, 2017

NED Remuneration and Total Voting Rights

January 10, 2017

Initial Launch of CSD500 in MENA

January 5, 2017

Correction: Notification of Major Interests

November 28, 2016

Correction - Block Listing Update

November 25, 2016

Ken James to lead Futura's R&D

November 16, 2016

Result of General Meeting

November 15, 2016

Result of Placing

October 27, 2016

MED2002: Breakthrough Results in $5 billion Market

September 7, 2016

Licenses CSD500 to Milsing for Southeast Europe

June 20, 2016

Manufacturing and Distribution Agreements with TTK

June 13, 2016

Recruitment Closes in MED2002 Study

May 4, 2016

Appointment of Non-Executive Director

March 7, 2016

Capital Markets Event

January 26, 2016

Remuneration of Non-Executive Directors

January 4, 2016

Extends Shelf Life of CSD500

December 16, 2015

Positive Regulatory Update on Pain Portfolio

November 24, 2015

Blocklisting Interim Review

November 23, 2015

MED2002 Clinical Trial Update

November 17, 2015

NHS Reimbursement for MED2002 as a Special

October 23, 2015

Licensing Agreement for MED2002

October 14, 2015

Grant of Options

September 10, 2015

Headline Results from Pain Relief Study

July 14, 2015

Notice of Pain Relief Portfolio Study Results

July 13, 2015

Commencement of MED2002 Clinical Trial

June 25, 2015

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

June 3, 2015

Pain Relief Portfolio: Study Update

May 18, 2015

Blue Diamond® Retail Roll-out

May 11, 2015

Pain Relief Portfolio Study Commences

March 18, 2015

AIM Disclosure

March 16, 2015

US Patent Extension for MED2002

February 5, 2015

Director Shareholding

January 22, 2015

Appointment of CRO for MED2002 Clinical Study

December 15, 2014

Update on Pain Relief Clinical Programme

December 1, 2014

Directorate Change

November 13, 2014

Blue Diamond Wins Market Share

November 10, 2014

Launch of CSD500 in the Netherlands and Belgium

October 9, 2014

Interim Results Replacement

September 11, 2014

Licenses CSD500 in South Korea

September 8, 2014

Notification of Interim Results

July 15, 2014

Result of General Meeting, and Issue of Equity

March 25, 2014

CSD500: Launch Update

March 10, 2014

Placing to raise ?12.0 million

March 7, 2014

US Roll-out of PET500

January 27, 2014

Licenses CSD500 to RFSU AB in the Nordic Region

December 19, 2013

Licenses CSD500 to Ansell in China

December 6, 2013

Award of CE Mark Certificate

October 17, 2013

← Newer · Older →